Iris Acquisition Corp II

CIK: 2077785•Ticker: IRAB

SPAC Overview

$169M
IPO Size
$169M
Trust (as of 2026-06-30)
Letter of Intent
Current Status
2026
IPO Year

Timeline Progress

About

Iris Acquisition Corp II is a generalist SPAC seeking a business combination with a high-quality, small- to mid-market private company that could benefit from a public listing and partnership with its team. It has not selected a target and intends to pursue an initial business combination using IPO and private-placement proceeds.

Investment Focus

Technology, Media, Telecommunications, Business Services, IT Services, Consumer, Hospitality, Real Estate, Education, Logistics, Mobility, Automotive, Industrial, FinTech, Cryptocurrency

Embarc dashboard

What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.

  • Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
  • Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
  • The full 8-K lifecycle timeline, each event linked to its filing
  • Price history across the unit, share and warrant tickers
  • Follow it, and see it change on your watchlist
Open in the dashboard

SPAC Team

Extended Team Information

The management and board bring cross-border transactional, operational and investment experience across North America, the Middle East, Asia and Europe, including backgrounds in private equity, investment banking, real estate, digital platforms and technology. The team previously sponsored Iris Acquisition Corp, which completed a business combination with Liminatus Pharma.

Key Information

IPO Date
February 3, 2026
State of Incorporation
E9
SIC
6770
SPAC Ticker
IRAB